GoodRx Holdings, Inc 10-Q for FY2024 Q2
GoodRx Holdings, Inc. (GDRX)
10-Q
2024-08-08
For: 2024-06-30
View Original
Added on
April 10, 2026
About this 10-Q
GoodRx Holdings, Inc filed this 10-Q on August 8, 2024, covering the quarter ended June 30, 2024 (FY2024 Q2).
Headline figures
Quarter ended June 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $200.61M
- up 5.8% from $189.68M a year earlier
- Net income
- $6.69M
- down 88.6% from net income of $58.79M a year earlier
- Diluted EPS
- $0.02
- down 85.7% from $0.14 a year earlier